Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kadouri

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Endocrine-Related Cancer|March 24, 2000
BRCA1/2 carriers and endocrine risk modifiersR Eeles, L Kadouri
Genes, Chromosomes & Cancer|April 3, 2001
A deletion/insertion mutation in the BRCA2 gene in a breast cancer family: a possible role of the Alu-polyA tail in the evolution of the deletionT Wang, I Lerer, Z Gueta, et al.
Harefuah|April 1, 1996
[Genetic counseling for families at high cancer risk]M Sagi, N Heching, L Kadouri, et al.
ESMO Open|October 11, 2021
Serologic response to COVID-19 infection and/or vaccine in cancer patients on active treatmentA Grinshpun, Y Rottenberg, I Z Ben-Dov, et al.
British Journal of Cancer|June 11, 2008
Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriersL Kadouri, Z Kote-Jarai, A Hubert, et al.
British Journal of Cancer|May 13, 2004
A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriersL Kadouri, Z Kote-Jarai, A Hubert, et al.
British Journal of Cancer|July 5, 2001
CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriersL Kadouri, D F Easton, S Edwards, et al.
Tissue Antigens|June 8, 2011
HLA-B35 correlates with a favorable outcome following adjuvant administration of an HLA-matched allogeneic melanoma vaccineM Lotem, L Kadouri, S Merims, et al.
Clinical Genetics|November 29, 2014
Genetic features of Lynch syndrome in the Israeli populationY Goldberg, I Barnes-Kedar, I Lerer, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Endocrine-Related Cancer|March 24, 2000
BRCA1/2 carriers and endocrine risk modifiersR Eeles, L Kadouri
Genes, Chromosomes & Cancer|April 3, 2001
A deletion/insertion mutation in the BRCA2 gene in a breast cancer family: a possible role of the Alu-polyA tail in the evolution of the deletionT Wang, I Lerer, Z Gueta, et al.
Harefuah|April 1, 1996
[Genetic counseling for families at high cancer risk]M Sagi, N Heching, L Kadouri, et al.
ESMO Open|October 11, 2021
Serologic response to COVID-19 infection and/or vaccine in cancer patients on active treatmentA Grinshpun, Y Rottenberg, I Z Ben-Dov, et al.
British Journal of Cancer|June 11, 2008
Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriersL Kadouri, Z Kote-Jarai, A Hubert, et al.
British Journal of Cancer|May 13, 2004
A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriersL Kadouri, Z Kote-Jarai, A Hubert, et al.
British Journal of Cancer|July 5, 2001
CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriersL Kadouri, D F Easton, S Edwards, et al.
Tissue Antigens|June 8, 2011
HLA-B35 correlates with a favorable outcome following adjuvant administration of an HLA-matched allogeneic melanoma vaccineM Lotem, L Kadouri, S Merims, et al.
Clinical Genetics|November 29, 2014
Genetic features of Lynch syndrome in the Israeli populationY Goldberg, I Barnes-Kedar, I Lerer, et al.
Pageof 1